Related Articles
Dendritic cell-based vaccination in metastatic melanoma patients: Phase II clinical trial
Immune responses in patients with esophageal cancer treated with SART1 peptide‑pulsed dendritic cell vaccine
Impact of mature dendritic cells pulsed with a novel WT1 helper peptide on the induction of HLA‑A2‑restricted WT1‑reactive CD8+ T cells
Novel approach to the characterization of melanoma associated-peptide-specific CTL lines from Japanese metastatic melanoma patients
Potential role of dendritic cell vaccination with MAGE peptides in gastrointestinal carcinomas